US · Healthcare · Medical Devices
EPS came in at 1.20 against a street estimate of 1.19 — a beat of 0.8%.
Analysts rate Integer Holdings Corp a strong buy (9 buy, 1 hold, 0 sell out of 10) with an average price target of $101.20.
| Fund | Stake |
|---|---|
| BlackRock Inc | 15.63% |
| Vanguard Portfolio Management, LLC | 6.03% |
| Amvescap Plc. | 5.80% |
| Morgan Stanley - Brokerage Accounts | 4.53% |
| Vanguard Capital Management, LLC | 4.53% |
| Dimensional Fund Advisors, Inc. | 4.37% |
| State Street Corp | 4.12% |
| AllianceBernstein L.P. | 3.84% |
| Document | Date |
|---|---|
| Results announced · Q3 2026 | 2026-08-03 |
| Board / officer change · Q2 2026 | 2026-06-26 |
| Board / officer change · Q2 2026 | 2026-05-22 |
| Quarterly report · Q2 2026 | 2026-04-30 |
| Results announced · Q2 2026 | 2026-04-30 |
| Proxy statement · Q2 2026 | 2026-04-06 |
| Annual report FY2025 | 2026-02-23 |
| Quarterly report · Q3 2025 | 2025-10-23 |
Readable in the app.
Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Integer Holdings Corp — free to start.
Google PlayApp StoreData updated 2026-08-05.